Digital Pathology: the Great Translation Debate - Scorecard - MDSpire

Digital Pathology: the Great Translation Debate

Conference discussions highlighted collaboration, resilience, and the realities of AI adoption in pathology labs

  • By

  • Jessica Allerton

  • May 20, 2026

  • 4 min

Share

Clinical Scorecard: Digital Pathology: the Great Translation Debate

At a Glance

CategoryDetail
ConditionTransition to digital pathology and AI integration
Key MechanismsSupport laboratories in managing workloads and diagnostic complexity
Target PopulationPathologists and laboratory professionals
Care SettingClinical pathology laboratories

Key Highlights

  • AI is a supportive tool, not a replacement for pathologists
  • Staffing shortages and burnout are prevalent in laboratories
  • Fragmented systems hinder operational performance and clinical efficiency
  • Cost and infrastructure are major barriers to DP and AI adoption
  • Future pathologists may prefer modern digital infrastructures

Guideline-Based Recommendations

Diagnosis

  • Reframe AI as a supportive tool within pathology workflows
  • Focus on improving triage, classification, and consistency

Management

  • Generate evidence of clinical and operational value for DP and AI tools
  • Implement continuous training for laboratory staff

Monitoring & Follow-up

  • Maintain workforce capacity and prepare for digital system failures

Risks

  • Operational, financial, and cultural barriers to DP and AI integration

Patient & Prescribing Data

Patients requiring pathology services

AI tools can enhance diagnostic decision-making while preserving human expertise

Clinical Best Practices

  • Encourage multidisciplinary collaboration in pathology
  • Focus on sustainable implementation of digital tools
  • Address recruitment and retention challenges in pathology workforce

Related Resources & Content

    Original Source(s)

    Digital Pathology: the Great Translation Debate

    • by Jessica Allerton

    • May 20, 2026

    Related Content

    FDA Approves Expanded Liquid Biopsy Panel

    Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

    DNA Quality Outweighs Bone Source

    Background DNA burden was more strongly associated with sequencing profile completeness than bone source in unidentified human remains.

    Could Digital Twins Forecast Forensic Risk?

    Researchers outline a proposed three-level framework spanning patient monitoring, ward operations, and forensic system planning.